Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Managing anaemia in cancer patients

Prof Matti Aapro, Prof Joachim Fandrey, Prof Dirk Schrijvers, Prof Anders Österborg
Managing anaemia in cancer patients ( Prof Matti Aapro, Prof Joachim Fandrey, Prof Dirk Schrijvers, Prof Anders Österborg )
27 Jan 2011

Oncotype DX testing to determine adjuvant therapy for breast cancer patients

Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain
Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )
25 Jan 2011

Soft Tissue Sarcoma management in Turkey

Berksoy Sahin - Çukurova University Medical School, Adana-Turkey
Soft Tissue Sarcoma management in Turkey ( Berksoy Sahin - Çukurova University Medical School, Adana-Turkey )
25 Jan 2011

The East European Sarcoma Group

Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow
The East European Sarcoma Group ( Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow )
25 Jan 2011

Oncotype DX testing to determine adjuvant therapy for breast cancer patients

Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain
Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )
24 Jan 2011

CA-125 in the follow up of patients with ovarian cancer in German

Prof Christian Marth - Innsbruck Medical University, Austria
CA-125 in the follow up of patients with ovarian cancer in German ( Prof Christian Marth - Innsbruck Medical University, Austria )
24 Jan 2011

Sing for Life: The NCRI Conference Performance

Tenovus Sing for Life Choir
Sing for Life: The NCRI Conference Performance ( Tenovus Sing for Life Choir )
20 Jan 2011

Molecular chaperones: cancer dependence and druggability

Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
Molecular chaperones: cancer dependence and druggability ( Prof Paul Workman - The Institute of Cancer Research, Sutton, UK )
19 Jan 2011

Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer

Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy
Pertuzumab and trastuzumab combo improves efficacy for HER2-positive breast cancer ( Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy )
19 Jan 2011

Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting

Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA
Exemestane potential for hormone-receptor positive, early-stage breast cancer in the adjuvant setting ( Dr Leif Ellisen - Massachusetts General Hospital, Boston, USA )
19 Jan 2011

Targeting of breast cancer tumour initiating cells

Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA
Targeting of breast cancer tumour initiating cells ( Dr Jeffrey Rosen – Baylor College of Medicine, Houston, USA )
19 Jan 2011

Issues with reliability in HER2 testing and avastin for metastatic breast cancer

Dr Edith Perez – Mayo Clinic, Florida, USA
Issues with reliability in HER2 testing and avastin for metastatic breast cancer ( Dr Edith Perez – Mayo Clinic, Florida, USA )
19 Jan 2011